Lawmakers Seek Input On Dx Regs, With Lab-Developed Tests In Focus
This article was originally published in The Gray Sheet
Executive Summary
The House Energy and Commerce Committee is seeking feedback on legislative initiatives Congress should enact in 2015 regarding regulation of diagnostics, and in particular in response to FDA's plan to regulate laboratory developed tests.
You may also be interested in...
Industry Wants More Details On Obama’s Precision Medicine Initiative
The president announced a new plan before Congress that could bolster federal funding for diagnostics and personalized medicine. Industry commended the administration’s move but was also cautious due to the lack of detail and says it wants to be at the drawing table when specifics are put to paper.
FDA Will Face Reforms, Oversight In Republican Congress, Analysts Say
Election gains by Republicans will embolden Congress to put FDA in its oversight “crosshairs,” as members of key Senate and House panels scrutinize how the agency is using its resources. Reforms could also come soon as part of the ongoing 21st Century Cures initiative.
Will Lab-Developed Test Makers Be Subject To Device Tax? It Depends, Shuren Suggests At Hearing
Lawmakers at a Sept. 9 House Energy and Commerce Subcommittee raised questions on whether FDA’s plans to regulate lab developed tests will also make labs subject to the device excise tax.